Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02042417
Other study ID # INRatio_CoaguChek
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received January 20, 2014
Last updated January 20, 2014
Start date February 2014

Study information

Verified date January 2014
Source Medical University of Vienna
Contact Reinhard Hahn, MD
Phone +431 40400
Email reinhard.hahn@meduniwien.ac.at
Is FDA regulated No
Health authority Austria: Ethikkommission
Study type Interventional

Clinical Trial Summary

We compare two POC-tests (INRario2 and CoaguChek) for the INR with the laboratory. Therefore, we take bloodsamples (capillary and venous blood) and put it on the tool. After the measuring, a number is shown = INR.

We develop a Bland-Altman-plot for the correlation between the tool value and the laboratory value to illustrate the applicability in the clinical daily routine.


Description:

Including criteria: ICU-patients from 18-99 years


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 0
Est. completion date
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

18-99 years, ICU patients

Exclusion Criteria:

Lupus erythematodes Anti-Phospholipid-Antikörper

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
INRatio2 and CoaguChek


Locations

Country Name City State
Austria MUVienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of POC-test-equipment with the standard method (laboratory) at ICU-patients outcome measure: Bland Altman plot 12 months No